The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase I SBIR Grant Entitled “Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle”
Doylestown, PA. July 17, 2020 – FCCDC is pleased to announce it has been awarded a Phase I SBIR from the NIH entitled “Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle” (1R43AI152788-01A1).